ArchiveSince the beginning of the 21th century, rapid economic development and an increasingly high standard of living have led to higher demands for medical services provided by hospitals in China. Patients not only seek painless procedures but also want to be free from stress and fear during the diagnosis and treatment. However, in the current diagnosis and treatment environment, many treatment methods unavoidably cause varying degrees of pain and discomfort, which is the most common symptom experienced by patients during medical treatment. To eliminate the pain of patients during medical treatment, some domestic tertiary hospitals and specialized hospitals have launched painless medical projects since the late 1990s, including painless childbirth, painless abortion and postoperative analgesia. However, these methods are still far from realizing the true concept of comfortable medical care. In recent years, we have proposed the concept of comfortable medical care and will briefly discuss its concept, significance and implementation.
Postoperative cognitive dysfunction (POCD) is a common postoperative complication in elderly patients, which lead to poor postoperative outcome. Ulinastatin is a urinary trypsin inhibitor. In recent years, its protective effect on postoperative cognitive function has been shown in several clinical researches. Ulinastatin can exert anti-inflammatory and anti-oxidative stress through multiple pathways, and it could also protect blood-brain barrier and intestinal mucosa barriers. These mechanisms may play a role in preventing POCD. This article reviewed the relevant clinical research, the protective mechanism of cognitive function and combination therapy of ulinastatin, to provide a guidance for clinical prevention of POCD in elderly patients.
Remimazolam mesylate is a new benzodiazepine, which is an ultra-short-acting sedative/anesthetic drug with mild cardiovascular and respiratory depression and no injection pain. Flumazenil, a benzodiazepine antagonist, reverses the adverse effects of remimazolam and further shortens the recovery time. This article reviewed the pharmacological properties, clinical application and safety of remimazolam in the field of painless bronchoscopy, in order to provide reference for clinical practice.
Hypoxia is the most common complication of painless gastrointestinal endoscopy anesthesia, so reducing the incidence of hypoxia is always an important task during sedative endoscopy. The best strategy to reduce hypoxia and other hypoxia-related adverse events is to prevent hypoxia during surgery, and airway management is one of the effective means. Therefore, in recent years, many related clinical studies have focused on airway management. The perioperative airway management tools for painless gastrointestinal endoscopy outside the operating room are constantly being updated. Making good use of existing tools and mastering new airway tools are helpful to reduce the incidence of intraoperative hypoxia and ensure patient safety. This article briefly reviewed the relevant research progress in order to provide clinical reference for clinical practice.
To observe the effects of esketamine on the quality of recovery and early cognitive function after radical mastectomy in elderly patients.
A total of 60 cases who were diagnosed with breast cancer and underwent selective unilateral modified radical mastectomy in Shaanxi provincial people's hospital from January to June 2021 were selected and divided into experimental group and control group according to numerical random table method, with 30 cases in each group. The experimental group was given intravenous injection of esketamine 0.1 mg/kg 10 minutes after endotracheal intubation, and the intraoperative injection was continued at 0.1 mg/kg every hour until 30 minutes before the end of the operation. The control group was given the same volume of normal saline. The quality of recovery and early cognitive function were compared between the two groups.
Riker sedation-agitation score and visual analog pain score of experimental group were lower than those of control group, and the differences were statistically significant (P<0.05). 24 h after surgery, the montreal cognitive assessment (MoCA) score of both groups decreased, but the MoCA score of the experimental group was higher than that of the control group, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
In elderly patients undergoing radical mastectomy, esketamine can improve the quality of recovery, relieve the pain during recovery, promote the recovery of postoperative cognitive function, and do not increase the postoperative adverse reactions.
To evaluate the clinical efficacy of different doses of oxycodone in relieving pain during the recovery period of general anesthesia during laparoscopic gynecological tumor surgery.
A total of 84 patients who underwent laparoscopic gynecological tumor surgery under general anesthesia in Shaanxi provincial cancer hospital from February 2018 to February 2019 were selected and randomly divided into group A (n=28), group B (n=27) and group C (n=29) by a randomized, single-blind, controlled study. 30 min before the end of the operation, group A was given 0.05 mg/kg oxycodone, group B was given 0.1 mg/kg oxycodone, and group C was given 0.15 mg/kg oxycodone. The VAS scores of three groups at 3 hours after surgery were compared. The changes of mean arterial pressure and heart rate were recorded at the end of operation (T0), immediately after extubation (T1), 5 minutes after extubation (T2) and 30 minutes after extubation (T3) in the three groups. The recovery period indicators and the incidence of complications were observed in the three groups.
Compared with group A, the VAS scores of group B and C were decreased at 3 h after surgery, and the difference was statistically significant (P<0.001). The mean arterial pressure, heart rate and Riker sedation-agitation scale of patients in group B and C were decreased at T1, T2 and T3, and the number of coughing was decreased. The differences were statistical significance (P<0.05). Compared with group A and B, the recovery time of consciousness and extubation time were longer in group C, and the differences were statistically significant (P<0.05). There was no significant difference in the incidence of complications within 3 h after surgery among 3 groups (P>0.05).
Intravenous injection of 0.1 mg/kg oxycodone hydrochloride injection 30 min before the end of surgery can effectively reduce the pain during the recovery period of general anesthesia in laparoscopic gynecological tumor surgery, relieve agitation during the recovery period, maintain stable vital signs, and does not affect the recovery of general anesthesia or increase complications.
To investigate the effect of low-dose esketamine on postpartum depression scores in women after caesarean section.
One hundred and eighty-six pregnant women with caesarean section were randomly divided into three groups: groups A and B were given esketamine 0.25 mg/kg after delivery, group C was given saline. In group A, esketamine 1 mg/kg was added to patient-controlled intravenous analgesia (PCIA) pump. Primary outcome: The effect of esketamine on the Edinburgh postnatal depression scale (EPDS). Secondary observable indicators included Pittsburgh sleep quality index (PSQI), visual analogue scale (VAS) and adverse effects.
At 5 and 7 days after operation, EPDS in both groups A and B were significantly lower than those before operation (P<0.05). At 7 days after operation, EPDS in both groups A and B were significantly lower than that in group C (P<0.05). There were significant differences in decline rate of EPDS among the three groups at 3, 5 and 7 days after operation (P<0.05). At 7 days after surgery, the decline rate of EPDS in group A and group B were 74.36% and 51.18%, respectively, which were significantly higher than that in group C (P<0.05). There were significant differences in PSQI among the three groups (P<0.05). There was no significant difference in postoperative VAS scores and number of PCIA compressions among the three groups (P>0.05). The incidence of blurred vision, dizziness and lethargy was the highest in group B, and the lowest in group C (P<0.05).
Intravenous administration of low dose esketamine can effectively and safely reduce the score of depression and improve the sleep quality in women after caesarean section.
To investigate the effect of propofol combined with etomidate on induction of general anesthesia in thyroid cancer surgery.
A total of 150 patients with thyroid cancer undergoing intubation and general anesthesia were randomly divided into group A (propofol anesthesia induction alone), group B (propofol+etomidate anesthesia induction, the volume ratio is 1∶1) and group C (propofol+etomidate anesthesia induction, the volume ratio is 2∶1), 50 cases in each group. The changes of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and bispectral index (BIS) were observed at 4 time points before anesthesia induction (T0), 1 min after induction (T1), immediately after tracheal intubation (T2) and 10 min after intubation (T3). The induction time, induction period and postoperative adverse reactions were also observed.
SBP, DBP and HR in group B and C were higher than those in group A at T1, T2, T3 (P<0.05). Compared with T0, SBP, DBP and HR were decreased at T1, T2 and T3 in group A (P<0.05). Compared with T0, SBP, DBP and HR were decreased at T1 in group B and C (P<0.05), and SBP was decreased at T2, T3 compared with T0 (P<0.05). There was no significant difference in BIS among the three groups at different times (P>0.05). The time of anesthesia induction to sleep in group C was lower than that in group A and B (P<0.05). The incidence of adverse reactions during anesthesia induction in group B and C was lower than that in group A (P<0.05). Compared with group A, there was no significant difference in the incidence of muscle fibrillation during anesthesia induction in group B and C (P>0.05). There was no significant difference in postoperative adverse reactions among the three groups (P>0.05).
Propofol combined with etomidate has more obvious advantages than propofol alone in the induction period of general anesthesia for thyroid cancer, and the propofol etomidate mixture with a volume ratio 2∶1 has more stable hemodynamics, less adverse reactions, and is safer and more effective.
To investigate the effects of remimazolam on postoperative nausea and vomiting (PONV) in patients undergoing gynecological laparoscopic operation (LO).
The patients undergoing gynecological LO were randomly divided into control group and experimental group, 40 cases in each group, both groups were given intravenous anesthesia. The control group received intravenous injection of propofol, sufentanil and cisatracurium for general anesthesia induction, and target-controlled infusion (TCI) of propofol and remifentanil for anesthesia maintenance. The experimental group received intravenous injection of remimazolam, sufentanil and cisatracurium for general anesthesia induction, and TCI of remimazolam and remifentanil for anesthesia maintenance. The occurrence of PONV within 0 - 8 h and 8 - 24 h after surgery were recorded. Mean arterial pressure (MAP), heart rate (HR) and pulse oxygen saturation were recorded before anesthesia induction (T0), after anesthesia induction (T1) and end of surgery (T2). The incidence of headache, dizziness and drowsiness within 24h after surgery were recorded.
The incidence of PONV in experimental group was lower than that in control group 0 - 8 h after operation (10.0% vs 32.5%, P<0.05). In control group, MAP and HR decreased significantly at T1 compared with T0 (P<0.05). The MAP and HR in control group were significantly lower than those in experimental group at T1 (P<0.05). The incidence of postoperative headache in control group was significantly higher than that in experimental group (27.5% vs 5.0%, P<0.05).
Remimazolam has a lower incidence of PONV within 0 -8 h after surgery, more stable intraoperative hemodynamics, and fewer adverse reactions than propofol for general anesthesia in patients with gynecological LO.
To explore the effect of ultra-sound guided rectus sheath block (RSB) combined with SLIPA laryngeal mask in pediatric laparoscopic surgery.
A total of 120 chilren undergoing laparoscopic surgery under general anesthesia were randomly divided into ultra-sound guided RSB combined with SLIPA laryngeal mask group (experimental group) and SLIPA mask group (control group), with 60 cases in each group. The mean arterial pressure, heart rate, plasma cortisol and blood glucose level were compared between the two groups at different time points. The usage of propofol and remifentanil, the recovery time, agitation and adverse reactions were compared between the two groups.
The mean arterial pressure and heart rate of experimental group were lower than those of control group after operation (P<0.05). The levels of plasma cortisol and blood glucose of experimental group were lower than those of control group during and after operation (P<0.05). The recovery time, usage of remifentanil and agitation rate during recovery and postoperative pain of experimental group were all lower than those of control group (P<0.05). The difference of postoperative pain between the two groups was correlated with the difference of blood glucose and cortisol (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
The ultra-sound guided RSB combined with SLIPA laryngeal mask airway anesthesia could be safely and effectively used in pediatric laparoscopic surgery. It has the advantages of less use of opioids, faster recovery, milder postoperative pain and lower perioperative stress.
To investigate the efficacy and safety of intravenous dexmedetomidine pretreatment in children with involuntary body reaction induced by propofol anesthesia.
Sixty children aged 3~9 years old undergoing elective surgery under general anesthesia were randomly divided into dexmedetomidine group and propofol group, with 30 cases in each group. Dexmedetomidine group was continuously injected with dexmedetomidine at the rate of 4 μg/kg·h for 5 min before anesthesia induction, and propofol group was injected with the same amount of normal saline at the same rate. The children in both groups were then given intravenous propofol, sufentanil and homeopathic atracurium for routine anesthesia induction. The incidence of involuntary body movement during anesthesia induction and recovery period were compared between the two groups.
Compared with the propofol group, the dexmedetomidine group had significantly lower incidence rate of overall involuntary body movement and moderate and severe body reaction during anesthesia induction (P<0.05). There were no significant differences in extubation time, duration of stay in anesthesia recovery room, incidence of adverse reactions during anesthesia recovery, sedation, agitation and pain degree between the two groups (P>0.05).
Dexmedetomidine pretreatment can safely and effectively reduce the incidence of involuntary body reaction induced by propofol during anesthesia induction.
To compare the advantages of laryngeal mask general anesthesia and intraspinal anesthesia in the rapid recovery of patients undergoing great saphenous varicose vein surgery.
A total of 301 patients with great saphenous varicose vein surgery were divided into spinal anesthesia group (n=195) and laryngeal mask general anesthesia group (n=106) according to the anesthesia method. The visual analogue scale (VAS) was used to evaluate the pain of the two groups at 24 hours after surgery. The postoperative ambulation time of patients, length of hospital stay and incidence of complications were observed.
Twenty-four hours after operation, the VAS score in the laryngeal mask anesthesia group was significantly lower than that of the intraspinal anesthesia group (P<0.001). The postoperative ambulation time in the laryngeal mask general anesthesia group was earlier than that in the spinal anesthesia group (P<0.001), and the hospitalization time was shorter than that in the spinal anesthesia group (P=0.005). The incidence of lumbar discomfort (P<0.001), headache (P=0.049), and urinary tract infection (P=0.027) in the postoperative spinal anesthesia group was significantly higher than that in the laryngeal mask anesthesia group.
Compared with intraspinal anesthesia, laryngeal mask general anesthesia can promote rapid recovery in patients with great saphenous varicose vein surgery.
To evaluate the sedative effect of low-dose remimazolam combined with etomidate or propofol for painless gastrointestinal endoscopy in the elderly patients.
A total of 129 patients underwent painless gastrointestinal endoscopy in our hospital were selected and divided into remimazolam-etomidate group (group RE), remimazolam-propofol group (group RP) and propofol group (group P) by random number table method, with 43 cases in each group. When a modified observer's assessment of alertness/sedation score≤1, patients were admitted to the endoscope. Blood pressure (BP), mean arterial pressure (MAP), heart rate and pulse oxygen saturation were recorded before induction (T0), when gastroscope reached pharyngeal cavity (T1), 3 min (T2) and 5 min (T3) after administration. The induction time, endoscopic examination time, recovery time, discharge time and the incidence of adverse events were recorded in the 3 groups. The cases of using cardiovascular drugs and the incidence of adverse reactions including hypoxia, hypotension, bradycardia, dizziness and postoperative nausea and vomiting (PONV) were recorded.
Forty-two patients in group P, 43 patients in group RE and RP completed the test. Compared with group P, the recovery time and discharge time were significantly shorter in group RE and RP (P<0.05). BP and MAP were higher in group RE at T1, T2, T3, and the utilization rate of hypotension, bradycardia and vasoactive drugs was significantly lower (P<0.05). The utilization rate of bradycardia and vasoactive drugs in group RP was significantly lower (P<0.05). There were no significant difference in the incidence of respiratory depression, hypoxia, dizziness, nausea and vomiting among the 3 groups (P>0.05).
When combined with affintanil 4 μg/kg, remimazolam 0.05 mg/kg combined with etomidate 0.15 mg/kg has slight circulatory inhibition and short recovery time, which can be safely and effectively used for gastrointestinal endoscopy sedation in elderly patients.
To observe the effect of continuous intravenous injection of lidocaine on intraoperative anesthetic dosage, postoperative pain and postoperative recovery quality of patients undergoing general anesthesia for radical mastectomy.
A total of 80 patients undergoing radical mastectomy under elective general anesthesia in our hospital from May 2021 to May 2022 were selected and divided into observation group and control group by random number table method, with 40 cases in each group. In the observation group, 1 mg/kg lidocaine was given intravenously before anesthesia induction, and then 2 mg/kg was pumped continuously until the end of operation. The control group was given equal volume normal saline in the same way. The intraoperative dosage of propofol and remifentanil were recorded. Visual analogue scale (VAS) was used to evaluate the degree of pain at 2, 6, 12 and 24 hours after operation, and the number of patients with rescue analgesia was observed. The 40 item quality of recovery score (QoR-40) was used to evaluate the postoperative recovery of patients at 24 h and 7 d after operation.
Compared with the control group, the intraoperative dosage of propofol and remifentanil in the observation group was less than that in the control group (P<0.05). At 2 h, 6 h and 12 h after operation, the VAS score of the observation group were lower than those of the control group, and the rescue analgesia rate of the observation group (7.5%) was lower than that of the control group (25%, P<0.05). At 24 h and 7 d after operation, the total score of QoR-40 in the observation group was higher than that in the control group (P<0.05).
Continuous intraoperative lidocaine injection can reduce the amount of anesthesia drugs, relieve postoperative pain and improve postoperative recovery quality in patients with general anesthesia during radical mastectomy.
To compare the effects of polyethylene glycol electrolyte (PEG) solution and sodium phosphate oral solution (SPOS) on intraoperative hemodynamics in elderly patients undergoing painless colonoscopy.
A total of 100 elderly patients were randomly divided into PEG group (P group, n=50) and SPOS group (S group, n=50). Before the operation, group P was given 3 L PEG diluted warm and cold water regimen, and group S was given 1.5 L SPOS diluted warm and cold water regimen. Blood pressure and heart rate (HR) were recorded before the operation (T0), on admission to the examination room (T1), anesthesia induction (T2), on admission (T3), 5 minutes after admission (T4), and at the end of the examination (T5). The dosage of intraoperative vasoactive drugs was also recorded.
Compared with group S, the incidence of intraoperative hypotension and bradycardia was lower, and the use of vasoactive drugs was less in group P (P<0.05).
PEG is superior to SPOS in maintaining intraoperative hemodynamic stability in elderly patients undergoing painless colonoscopy.
To investigate the influence of age and gender on the median effective dose of remimazolam for painless gastroscopy.
Patients who underwent painless gastroscopy were divided into 6 groups according to age and gender, group A: young women (18~44 years old), group B: middle-aged women (45~59 years old), group C: elderly women (60~75 years old), group D: young men (18~44 years old), group E: middle-aged men (45~59 years old), and group F: elderly men (60~75 years old). Patients were administrated with 10 μg/kg alfentanil and different dose of remimazolam, and 0.20 mg/kg was set as the initial dose. The dose of remimazolam of the next patient was determined by the Dixon’ up-down modified sequential method. The sedative effect of different doses of remimazolam and the occurrence of adverse reactions in each group were recorded. Probabilistic regression analysis was used to analyze the median effective dose (ED50), 95% confidence interval (CI) and dose-response relationship of remimazolam in each group.
A total of 167 patients were finally enrolled, including 26 cases in group A, 25 cases in group B, 27 cases in group C, 28 cases in group D, 33 cases in group E and 28 cases in group F. The ED50 of remimazolam in group A (0.33 mg/kg, 95%CI: 0.26~0.37 mg/kg) was higher than that in group C~group F, and the differences were statistically significant (P<0.05). The ED50 of group B (0.32 mg/kg, 95%CI: 0.24~0.36 mg/kg) was higher than that in group C, E and F, and the differences were statistically significant. There was no statistically difference in ED50 and adverse reactions among the other groups.
ED50 of remimazolam combined with alfentanil used for painless gastroscopy in young and middle-aged females was higher than that in same age males and elderly women.
Esketamine, a dextral isomers of ketamine, is an anesthetic drug with analgesia, amnesia and loss of consciousness. It also has hemodynamic stability, less respiratory inhibition, anti-inflammatory and neuroprotective effects. It is one of the priority drugs for analgesic and sedative treatment of critically ill patients in intensive care units (ICU). This article reviewed the pharmacological effects of esketamine and its clinical application in ICU.
Etomidate is widely used in clinical anesthesia management because of its good cardiovascular stability. However, it has a transient inhibitory effect on adrenocortical function. Dexamethasone is a widely used glucocorticoid during perioperative period, which can obviously inhibit the function of hypothalamic pituitary adrenal cortical axis. In clinical practice, the combination of these two drugs is very common. This article reviewed the effects of these two drugs on adrenal cortisol secretion.